310 related articles for article (PubMed ID: 19907151)
21. Non-HFE haemochromatosis.
Wallace DF; Subramaniam VN
World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary and acquired iron overload].
de Korwin JD
Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
[TBL] [Abstract][Full Text] [Related]
23. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
[TBL] [Abstract][Full Text] [Related]
24. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
[TBL] [Abstract][Full Text] [Related]
25. Hemochromatosis: genetics and pathophysiology.
Beutler E
Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
[TBL] [Abstract][Full Text] [Related]
26. Hemochromatosis: genetic testing and clinical practice.
Zoller H; Cox TM
Clin Gastroenterol Hepatol; 2005 Oct; 3(10):945-58. PubMed ID: 16234038
[TBL] [Abstract][Full Text] [Related]
27. Non-HFE hepatic iron overload.
Pietrangelo A; Caleffi A; Corradini E
Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
[TBL] [Abstract][Full Text] [Related]
28. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
[TBL] [Abstract][Full Text] [Related]
29. [Iron overload disease: recent findings].
Licata A; Brucato V; Di Marco V; Barbaria F; Craxì A
Ann Ital Med Int; 2004; 19(3):145-54. PubMed ID: 15529941
[TBL] [Abstract][Full Text] [Related]
30. Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.
Nelson JE; Kowdley KV
Curr Gastroenterol Rep; 2005 Feb; 7(1):71-80. PubMed ID: 15701302
[TBL] [Abstract][Full Text] [Related]
31. [Iron overload and insulin resistance].
Vantyghem MC; Girardot C; Boulogne A; Wemeau JL
Presse Med; 2005 Nov; 34(19 Pt 1):1391-8. PubMed ID: 16292193
[TBL] [Abstract][Full Text] [Related]
32. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
33. Iron overload in the Asian community.
Lok CY; Merryweather-Clarke AT; Viprakasit V; Chinthammitr Y; Srichairatanakool S; Limwongse C; Oleesky D; Robins AJ; Hudson J; Wai P; Premawardhena A; de Silva HJ; Dassanayake A; McKeown C; Jackson M; Gama R; Khan N; Newman W; Banait G; Chilton A; Wilson-Morkeh I; Weatherall DJ; Robson KJ
Blood; 2009 Jul; 114(1):20-5. PubMed ID: 19342478
[TBL] [Abstract][Full Text] [Related]
34. Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
Altès A; Bach V; Ruiz A; Esteve A; Remacha AF; Sardà MP; Felez J; Baiget M
Ann Hematol; 2009 Apr; 88(4):341-5. PubMed ID: 18820912
[TBL] [Abstract][Full Text] [Related]
35. Rare causes of hereditary iron overload.
Ponka P
Semin Hematol; 2002 Oct; 39(4):249-62. PubMed ID: 12382200
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathogenesis of hereditary hemochromatosis.
Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C
Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690
[TBL] [Abstract][Full Text] [Related]
37. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.
Montosi G; Donovan A; Totaro A; Garuti C; Pignatti E; Cassanelli S; Trenor CC; Gasparini P; Andrews NC; Pietrangelo A
J Clin Invest; 2001 Aug; 108(4):619-23. PubMed ID: 11518736
[TBL] [Abstract][Full Text] [Related]
38. EASL clinical practice guidelines for HFE hemochromatosis.
European Association For The Study Of The Liver
J Hepatol; 2010 Jul; 53(1):3-22. PubMed ID: 20471131
[TBL] [Abstract][Full Text] [Related]
39. [Hypersiderosis and dissiderosis in the context of data on hemochromatosis microelementosis].
Smirnov OA
Arkh Patol; 2008; 70(3):3-8. PubMed ID: 18727423
[TBL] [Abstract][Full Text] [Related]
40. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
